Health

NY Times -  The Trump administration announced on Tuesday that it intended to end a Biden-era program that for the past two years has helped tamp down the cost of monthly premiums for drug coverage for people on Medicare.

The decision means that millions of Americans 65 and older could face higher Medicare drug premiums next year, when the cost of living is already a major concern. That could be politically damaging for Republicans in the midterm elections. In the weeks leading up to November, Medicare beneficiaries could experience sticker shock while shopping for next year’s drug plan./